New Market Gap for Anti Depressants due to increase in mental health problems reports OnlinePharmacyCare.com
A shocking uprise in depression related disorders has created increased business for such medicine providers.
- (1888PressRelease) September 17, 2012 - San Francisco, CA - The sales of medicine to bring unipolar depression under control still offers considerable openings to make money, as revealed by a recent report. The reason for this is the discovery of a larger prevalence of disorders related to depression across the globe. Moreover, owing to the existing rate of response of patients being very low, more than 25% of all individuals suffering from depression simply do not react to first-line medicines.
Nevertheless, the increasing quantity of generic medicine in this sector is projected to make it ever more tedious for advertisers to attain a high status for upcoming therapies under a big label. AstraZeneca's Seroquel XL, Seroquel Prolong, and Seroquel XR, as well as the generic models of this medicine in addition to Bristol-Myers Squibb/Otsuka Pharmaceutical's Abilify continually augment their patients' intake as supplemental cures for major disorders.
New and upcoming depression medicine will have to penetrate into a saturated and generic-dominated medicine market. This seems to hold true as a result of a lack of technical disparity between the present advertised Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Norepinephrine Reuptake Inhibitors (SNRIs). Provided the grip that these existing medicines have in the context of options price, as well as physician comfort, the upcoming medicines will probably not be used first.
The proceeds of medicines to cure cases of depression in these seven main marketplaces will fall from USD $12.3 billion in the year 2011 to approximately USD $10 billion in the year 2021. This will mostly be the consequence of the erosion of main agents, especially in the United States. The report further adds that a large part of the fall in this market in the aforementioned years is forecasted to be because of the downfall of big name brand medicines.
About OnlinePharmacyCare.com:
OnlinePharmacyCare.com (http://www.onlinepharmacycare.com/) is a well-reputed online provider of a wide range of medical products that range from mens health to eye care. Consultation is provided and the business operates under proper rules and regulations regarding the safety required to buy seroquel online, abilify, aripiprazole, seroquel, quetiapine, cymbalta, and dueloxetine.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam